PDE6G and benign prostatic hyperplasia: Similarly, gene expression profiling analysis of various prostate cancer cell lines from the CCLE database demonstrated that, compared with that in the benign prostatic hyperplasia cell line BPH-1, CEL gene expression was decreased in most prostate cancer cells, while PDE6G and CYP3A4 gene expression was increased (Fig. 12B).